XML 17 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Mar. 31, 2016
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]      
Net sales $ 2,103.1 $ 1,503.0 $ 1,352.5
Cost of sales 1,746.6 1,248.6 1,118.9
Gross profit 356.5 254.4 233.6
Selling, general and administrative expenses 245.8 203.2 170.0
Restructuring expenses 16.0 10.9 16.6
Impairment charges 2.5 0.0 9.9
Gain on sale of facilities 0.0 (2.0) 0.0
Operating income 92.2 42.3 37.1
Interest expense (25.6) (17.2) (11.1)
Other expense - net (3.3) (4.3) (35.9)
Earnings (loss) before income taxes 63.3 20.8 (9.9)
(Provision) benefit for income taxes (39.5) (5.9) 8.9
Net earnings (loss) 23.8 14.9 (1.0)
Net earnings attributable to noncontrolling interest (1.6) (0.7) (0.6)
Net earnings (loss) attributable to Modine $ 22.2 [1] $ 14.2 [2] $ (1.6)
Net earnings (loss) per share attributable to Modine shareholders:      
Basic (in dollars per share) $ 0.44 $ 0.29 $ (0.03)
Diluted (in dollars per share) $ 0.43 $ 0.29 $ (0.03)
Weighted-average shares outstanding:      
Basic (in shares) 49.9 47.8 47.3
Diluted (in shares) 50.9 48.3 47.3
[1] During fiscal 2018, restructuring expenses totaled $1.7 million, $0.4 million, $9.4 million, and $4.5 million for the quarters ended June 30, 2017, September 30, 2017, December 31, 2017, and March 31, 2018, respectively (see Note 5). During the third quarter of fiscal 2018, the Company recorded a $1.3 million asset impairment charge related to a manufacturing facility in Austria (see Note 5). During the fourth quarter of fiscal 2018, the Company recorded a $1.2 million impairment charge related to intangible assets (see Note 12). During fiscal 2018, costs directly related to the acquisition and integration of Luvata HTS totaled $1.6 million, $1.1 million, $1.0 million, and $0.6 million for the quarters ended June 30, 2017, September 30, 2017, December 31, 2017, and March 31, 2018, respectively (see Note 2). The Company recorded charges totaling $35.7 million and $2.3 million resulting for certain income tax effects of recently-enacted U.S. tax legislation in the quarters ended December 31, 2017 and March 31, 2018, respectively (see Note 7). During the fourth quarter of fiscal 2018, the Company reversed a portion of a valuation allowance related to a foreign tax jurisdiction, and, as a result, recorded an income tax benefit of $2.8 million (see Note 7).
[2] During fiscal 2017, restructuring expenses totaled $2.3 million, $2.1 million, $1.6 million, and $4.9 million for the quarters ended June 30, 2016, September 30, 2016, December 31, 2016, and March 31, 2017, respectively (see Note 5). During fiscal 2017, the Company sold two previously-closed manufacturing facilities in its Americas segment and a facility in its Europe segment and recognized net gains totaling $1.2 million and $0.8 million in the quarters ended September 30, 2016 and March 31, 2017, respectively. During fiscal 2017, costs directly related to the acquisition and integration of Luvata HTS totaled $1.4 million, $3.0 million, $7.2 million, and $3.2 million for the quarters ended June 30, 2016, September 30, 2016, December 31, 2016, and March 31, 2017, respectively (see Note 2). During the fourth quarter of fiscal 2017, the Company recorded a deferred tax valuation allowance related to a foreign tax jurisdiction, and, as a result, recorded income tax expense of $2.0 million (see Note 7).